E 13 (Griseofulvin (Ultramicrocrystalline) 125 mg)
Pill with imprint E 13 is White, Round and has been identified as Griseofulvin (Ultramicrocrystalline) 125 mg. It is supplied by Sigmapharm Laboratories, LLC.
Griseofulvin is used in the treatment of dermatophytosis; tinea cruris; onychomycosis, toenail; onychomycosis, fingernail; tinea barbae (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Griseofulvin 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E 13
Griseofulvin (Ultramicrocrystalline)
- Imprint:
- E 13
- Strength:
- 125 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sigmapharm Laboratories, LLC
- National Drug Code (NDC):
- 64980-0184
More about griseofulvin
- Griseofulvin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 13 Reviews
- Drug class: miscellaneous antifungals
Consumer resources
- Griseofulvin
- Griseofulvin Microsize Tablets
- Griseofulvin Ultramicrosize Tablets
- Griseofulvin Microsize Oral Suspension
- Griseofulvin (Advanced Reading)
Other brands: Grifulvin V, Fulvicin U/F, Gris-PEG, Fulvicin P/G
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
